Betafuse
General data
Product class:
Authorized package
Medicinal product class:
Veterinary medicine
Package code:
1693492
Name of medicinal product:
Betafuse
Active substances:
Betamethasone+Fusidic acid
Estonian
,
English
,
Latin
ATC code:
QD07CC80
Dosage form:
gel
Route of administration:
cutaneous use
Strengh:
1mg+5mg 1g
Amount in package:
30g 1TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
For the treatment of acute surface pyoderma in the dog, such as acute moist dermatitis (‘hot spots’) and intertrigo (skin fold dermatitis), caused by Gram-positive bacteria sensitive to fusidic acid.
Safety features:
No
Summary of product characteristics (SPC):
(last updated 02 September 2021)
Package information leaflet (PIL):
EST
(last updated 02 September 2021)
Labelling:
(last updated 02 September 2021)
Withdrawal time:
Ei rakendata.
Species:
koer
Last imported to Estonia:
Never imported to Estonia
Marketing authorization
Marketing authorization holder:
Norbrook Laboratories (Ireland) Limited
Marketing authorization number:
1992
Marketing authorization issued on:
30 September 2016
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
Decentralised
Entry/Changing date: 16 November 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription